Author

Zhihui Lang

Observed names: Z Lang, Z. Lang

Observed institutions: Rush University Medical Center, Ford Motor Company (United States), Cleveland Clinic, Children's National, Emory University, George Washington University, University of Manchester, Endo Pharmaceuticals (United States), Medizinische Hochschule Hannover, Essen University Hospital, Royal Marsden Hospital, The Christie Hospital, Rush University, New York University, Vanderbilt University Medical Center

OpenAlex ID: A5112017868

Phase I Evaluation of a Fully Human Anti–αv Integrin Monoclonal Antibody (CNTO 95) in Patients with Advanced Solid Tumors

2007 · Saifee A. Mullamitha, Nhuan C. Ton, et al. · Clinical Cancer Research · 148

A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma

2011 · on the behalf of the CNTO 95 Investigators, S O'Day, et al. · British Journal of Cancer · 123

PDF

Alpha-v Integrins as Therapeutic Targets in Oncology

2007 · Jeffrey A. Nemeth, Marian T. Nakada, et al. · Cancer Investigation · 100

Ganglioside GD1a Enhances VEGF-Induced Endothelial Cell Proliferation and Migration

2001 · Zhihui Lang, Michael Guerrera, et al. · Biochemical and Biophysical Research Communications · 64

Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma in situ of the bladder

2014 · Michael S. Cookson, Sam S. Chang, et al. · Therapeutic Advances in Urology · 49

Aerosolized neutral endopeptidase reverses ozone-induced airway hyperreactivity to substance P

1992 · C. G. Murlas, Z. Lang, et al. · Journal of Applied Physiology · 36

A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human αv integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer

2010 · Franklin M. Chu, Joel Picus, et al. · Investigational New Drugs · 30

Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma

2011 · Steven J. O’Day, Anna C. Pavlick, et al. · Investigational New Drugs · 28

Neutral Endopeptidase of a Human Airway Epithelial Cell Line Recovers after Hypochlorous Acid Exposure: Dexamethasone Accelerates This by Stimulating Neutral Endopeptidase mRNA Synthesis

1992 · Zhihui Lang, Christopher G. Murlas · American Journal of Respiratory Cell and Molecular Biology · 22

HOCl causes airway substance P hyperresponsiveness and neutral endopeptidase hypoactivity

1990 · C. G. Murlas, T. P. Murphy, et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 22

Phase I study of CNTO 95, a fully human monoclonal antibody (mAb) to αv integrins, in patients with solid tumors

2005 · G. C. Jayson, S. Mullamitha, et al. · Journal of Clinical Oncology · 18

An autonomously replicating eukaryotic expression vector with a tetracycline-responsive promoter

1996 · Zhihui Lang, Jay M. Feingold · Gene · 16

Dexamethasone reduces tachykinin but not ACh airway hyperreactivity after 03

1993 · Christopher G. Murlas, Zhihui Lang, et al. · Lung · 14

Dexamethasone increases airway epithelial cell neutral endopeptidase by enhancing transcription and new protein synthesis

1993 · Zhihui Lang, ChristopherG. Murlas · Lung · 8

HOCl exposure of a human airway epithelial cell line decreases its plasma membrane neutral endopeptidase

1991 · Zhihui Lang, Christopher G. Murlas · Lung · 8

Randomized phase II study of the safety and efficacy of a human anti-αv integrin monoclonal antibody (CNTO 95) alone and in combination with dacarbazine in patients with stage IV metastatic melanoma: 12-month results

2009 · C. Loquai, A. Pavlick, et al. · Journal of Clinical Oncology · 5

Preliminary Results of CNTO 328, an Anti-Interleukin (IL)-6 Monoclonal Antibody (mAb), in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma.

2007 · Robert F. Manges, Heather J. Sutherland, et al. · Blood · 3

1783 Safety of Intravesical Mycobacterial Cell Wall-dna Complex Given Immediately Postsurgery in Patients With Non-muscle-invasive Bladder Cancer

2012 · Alvaro Morales, David Jablonski, et al. · The Journal of Urology · 2

Phase I study of CNTO 95, a fully human monoclonal antibody to αv integrins, docetaxel, and prednisone in hormone refractory prostate cancer patients (HRPCP)

2007 · F. M. Chu, J. Picus, et al. · Journal of Clinical Oncology · 1

Intravesical (IVe) valrubicin for treatment of carcinoma in situ (CIS) of the bladder: Use in clinical practice.

2012 · Michael S. Cookson, Christine Francis Lihou, et al. · Journal of Clinical Oncology

#296 Monosomy 7 transformation in donor cells following allogeneic bone marrow transplantation for aplastic anemia

1999 · Z. Lang, P. Dinndorf, et al. · Journal of Pediatric Hematology/Oncology

Works count: 22

Citation count: 697

H-index: 13

I10-index: 13